Eeva Moilanen

2.0k total citations · 1 hit paper
30 papers, 1.7k citations indexed

About

Eeva Moilanen is a scholar working on Rheumatology, Physiology and Immunology. According to data from OpenAlex, Eeva Moilanen has authored 30 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 7 papers in Physiology and 7 papers in Immunology. Recurrent topics in Eeva Moilanen's work include Rheumatoid Arthritis Research and Therapies (12 papers), Systemic Lupus Erythematosus Research (5 papers) and Asthma and respiratory diseases (5 papers). Eeva Moilanen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Systemic Lupus Erythematosus Research (5 papers) and Asthma and respiratory diseases (5 papers). Eeva Moilanen collaborates with scholars based in Finland, Sweden and United Kingdom. Eeva Moilanen's co-authors include Hannu Kankaanranta, Riku Korhonen, Aleksi Lahti, Heikki Vapaatalo, Peter J. Barnes, Mark A. Giembycz, Xianzhi Zhang, Mark A. Lindsay, Markku Korpela and Mari Hämäläinen and has published in prestigious journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Eeva Moilanen

30 papers receiving 1.6k citations

Hit Papers

Nitric Oxide Production and Signaling in Inflammation 2005 2026 2012 2019 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nitric Oxide Production and Signaling in Inflammation
    2005 805 citations Riku Korhonen, Aleksi Lahti et al. Current Drug Targets - Inflammation & Allergy profile →

Peers

Eeva Moilanen
Riku Korhonen Finland
Yubin Luo China
Hyung-In Yang South Korea
Elaine M. Conner United States
Aleksi Lahti Finland
Kyoung Soo Kim South Korea
Keisuke Hagihara Japan
Junsuke Arimitsu Japan
Sanaa A. Kenawy Egypt
Akihide Koda Japan
Riku Korhonen Finland
Eeva Moilanen
Citations per year, relative to Eeva Moilanen Eeva Moilanen (= 1×) peers Riku Korhonen

Countries citing papers authored by Eeva Moilanen

Since Specialization
Citations

This map shows the geographic impact of Eeva Moilanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eeva Moilanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eeva Moilanen more than expected).

Fields of papers citing papers by Eeva Moilanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eeva Moilanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eeva Moilanen. The network helps show where Eeva Moilanen may publish in the future.

Co-authorship network of co-authors of Eeva Moilanen

This figure shows the co-authorship network connecting the top 25 collaborators of Eeva Moilanen. A scholar is included among the top collaborators of Eeva Moilanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eeva Moilanen. Eeva Moilanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moilanen, Eeva, et al.. (2024). Macrophage and chondrocyte phenotypes in inflammation. Basic & Clinical Pharmacology & Toxicology. 135(5). 537–549. 2 indexed citations
2.
Heikkinen, Anna Maria, Antti Kuuliala, Kirsi Ahola, et al.. (2018). Activity of rheumatoid arthritis correlates with oral inflammatory burden. Rheumatology International. 38(9). 1661–1669. 13 indexed citations
3.
Heikkinen, Anna Maria, Antti Kuuliala, Kirsi Ahola, et al.. (2018). Anti‐rheumatic medication and salivary MMP‐8, a biomarker for periodontal disease. Oral Diseases. 24(8). 1562–1571. 18 indexed citations
4.
5.
6.
Kiiski, Heikki, Jaakko Långsjö, Jyrki Tenhunen, et al.. (2016). Time-courses of plasma IL-6 and HMGB-1 reflect initial severity of clinical presentation but do not predict poor neurologic outcome following subarachnoid hemorrhage. eNeurologicalSci. 6. 55–62. 15 indexed citations
7.
Peltomaa, Ritva, et al.. (2016). The Costs of Rheumatoid Arthritis In Finland. Value in Health. 19(7). A536–A536. 1 indexed citations
8.
Lindström, Outi, Krista Kuuliala, Leena Kylänpää, et al.. (2016). Association of Matrix Metalloproteinases -7, -8 and -9 and TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study. PLoS ONE. 11(8). e0161480–e0161480. 19 indexed citations
9.
Leirisalo‐Repo, Marjatta, Hannu Kautiainen, Leena Laasonen, et al.. (2012). Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study). Annals of the Rheumatic Diseases. 72(6). 851–857. 69 indexed citations
10.
Korhonen, Riku & Eeva Moilanen. (2009). Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis. Basic & Clinical Pharmacology & Toxicology. 106(1). 13–21. 25 indexed citations
11.
Haukka, Matti, Olli Oksala, Esko Pohjala, et al.. (2006). Synthesis, ocular effects, and nitric oxide donation of imidazole amidoximes. European Journal of Medicinal Chemistry. 41(9). 1073–1079. 7 indexed citations
12.
Korhonen, Riku, Aleksi Lahti, Hannu Kankaanranta, & Eeva Moilanen. (2005). Nitric Oxide Production and Signaling in Inflammation. Current Drug Targets - Inflammation & Allergy. 4(4). 471–479. 805 indexed citations breakdown →
13.
Hatakka, Katja, J. Martio, Markku Korpela, et al.. (2003). Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot study. Scandinavian Journal of Rheumatology. 32(4). 211–215. 173 indexed citations
14.
Moilanen, Eeva, et al.. (2001). Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis. European Journal of Pharmacology. 431(3). 365–371. 62 indexed citations
15.
Kankaanranta, Hannu, Mark A. Lindsay, Mark A. Giembycz, et al.. (2000). Delayed eosinophil apoptosis in asthma. Journal of Allergy and Clinical Immunology. 106(1). 77–83. 138 indexed citations
16.
Moilanen, Eeva, et al.. (2000). Enhancement of human eosinophil apoptosis by fluticasone propionate, budesonide, and beclomethasone. European Journal of Pharmacology. 406(3). 325–332. 58 indexed citations
17.
Asmawi, Mohd Zaini, et al.. (1999). Effects of nitric oxide donors GEA 3162 and SIN-1 on ethanol-induced gastric ulceration in rats. European Journal of Pharmacology. 378(1). 123–127. 8 indexed citations
18.
Kankaanranta, Hannu, et al.. (1999). Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells. European Journal of Pharmacology. 382(2). 111–117. 58 indexed citations
19.
Moilanen, Eeva & Heikki Vapaatalo. (1998). [Noble prize in medicine to nitric oxide researchers].. PubMed. 114(24). 2517–20. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riku Korhonen Breakdown of academic impact, for papers by Yubin Luo Breakdown of academic impact, for papers by Hyung-In Yang Breakdown of academic impact, for papers by Elaine M. Conner Breakdown of academic impact, for papers by Aleksi Lahti Breakdown of academic impact, for papers by Kyoung Soo Kim Breakdown of academic impact, for papers by Keisuke Hagihara Breakdown of academic impact, for papers by Junsuke Arimitsu Breakdown of academic impact, for papers by Sanaa A. Kenawy Breakdown of academic impact, for papers by Akihide Koda
Rankless by CCL
2026